{"id":41207,"date":"2017-03-15T06:43:47","date_gmt":"2017-03-15T05:43:47","guid":{"rendered":"https:\/\/rss.nova-institut.net\/public.php?url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FBiotechNow%2F%7E3%2FAeLgCkSOnMI%2Fbio2017-a-peek-at-pavilions-european-commission"},"modified":"2017-03-14T15:15:20","modified_gmt":"2017-03-14T14:15:20","slug":"bio2017-a-peek-at-pavilions-european-commission","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/bio2017-a-peek-at-pavilions-european-commission\/","title":{"rendered":"#BIO2017: A Peek at Pavilions | European Commission"},"content":{"rendered":"<p><strong>Breaking Buzz is BIO\u2019s newest blog series that reaches across the globe to bring an insider\u2019s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention.<\/strong><\/p>\n<h3>The \u20ac80 billion Incentive in Europe<\/h3>\n<p>The buzz words in Brussels right now are breakthrough, inclusion, and flexibility, as the European Commission touts big innovations underway throughout Europe. This is especially good news for SMEs who seek substantial funding, pain-free internationalization, and an environment of sustainable growth \u2013 all things backed up by nearly \u20ac80 billion available through Horizon 2020, the European framework program for research and innovation. This, plus innovative incentives, customization, and bold partnering opportunities serve as the EC\u2019s global calling card that will be on deck at the BIO International Convention this June in San Diego, California.<\/p>\n<p>\u201cHorizon 2020, launched in 2014, is the initiative behind this \u20ac80 billion investment and is fully backed by the European Parliament. It is the biggest integrated research funding programme undertaken by the European Union ever; in fact, it\u2019s among the largest in the world,\u201d according to Ruxandra Draghia-Akli, the Deputy Director-General for Research Programmes at the European Commission who is clearly enthusiastic about the landscape before her. \u201cIt provides tailor-made instruments for the varying needs of health research companies and SMEs. It\u2019s designed for companies looking for high growth \u2013 with disruptive ideas \u2013 offering them funding and aggressive business support.\u201d<\/p>\n<p>The instruments to which she refers are the very components that make up Horizon 2020: sizable grants for large collaborative projects, world-class business support and mentoring, and robust partnerships between public, private, academic and industrial researcher enterprises \u2013 each with open access to a huge common European market.<\/p>\n<p>Think of it as a harmonization among scientific and regulatory experts in Member states across the EU, working together and actually delivering open and transparent policy.<\/p>\n<p>Tuned-in to this harmony is Meelis Kadaja, Director of Business Development for Icosagen, a research provider for biopharmaceutical and biotechnology industries. \u201cParticipation in Horizon 2020 has given us the opportunity to redefine the identity of our company and bring a novel technology to the market that enables us to become a front runner in our field. It has served as a proof of high quality of research and innovation done for our customers and partners, and helped us to gain their trust.\u201d<\/p>\n<p>Mr. Kadaja points out that the most appealing part of participating in Horizon 2020, in addition to the \u20ac1,129,800, is the non-dilutive funding and support of innovation, and its commercialization. It promotes, in his words, a \u201cfeeling that your work matters to the EU.\u201d<\/p>\n<p>Back at the European Commission Dr. Draghia-Akli stresses, \u201cWe are looking for highly innovative SMEs with global ambitions, companies that are emboldened to grow. We want you to know for certain that Europe is open for business in a big way, and we have considerable support for SMEs operating in the life science cycle, particularly those with breakthrough innovation.\u201d<\/p>\n<p>The application process for Horizon 2020 is entirely online. To apply, click Apply Here.<\/p>\n<p>To learn more about Horizon 2020 and other initiatives, visit the European Commission Pavilion at the upcoming BIO International Convention, June 19-22, 2017 in San Diego where you will find:<\/p>\n<p>Ruxandra Draghia-Akli, Deputy Director-General Research and Innovation, European Commission<br \/>\nCarlo Incerti, Genzyme, Head Global Medical Affairs, Chair EuropaBio<br \/>\nChris Austin, Director NCATS, IRDiRC Chair<br \/>\nKatherine Needleman, FDA Office of Orphan Products Development<br \/>\nDiego Ardigo, Chiesi Farmaceutici, Chair of the Therapies Scientific Committee, IRDiRC<\/p>\n<p>Dr. Draghia-Akli will also be a panelist for a session entitled \u201cFast Track to Orphan Drugs\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Breaking Buzz is BIO\u2019s newest blog series that reaches across the globe to bring an insider\u2019s preview into the hottest international and partnering trends coming to San Diego for the BIO International Convention. The \u20ac80 billion Incentive in Europe The buzz words in Brussels right now are breakthrough, inclusion, and flexibility, as the European Commission [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[5796],"supplier":[2194,1829,2317,5585,7768,13210,13211,2713],"class_list":["post-41207","post","type-post","status-publish","format-standard","hentry","category-bio-based","tag-biotechnology","supplier-biotechnology-innovation-organization-bio","supplier-europabio","supplier-european-commission","supplier-european-union","supplier-horizon-2020","supplier-icosagen","supplier-irdirc","supplier-us-food-and-drug-administration-fda"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/41207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=41207"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/41207\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=41207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=41207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=41207"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=41207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}